Briacell Therapeutics Corp (BCTX) — Strategic Asset Allocation Index
Briacell Therapeutics Corp (BCTX) has a Strategic Asset Allocation Index of 1.9% as of January 2026. Strategic assets (PP&E of $- plus long-term investments of $582.46K) total $582.46K, measured against net assets of $30.21 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Briacell Therapeutics Corp Strategic Asset Allocation Index (2017–2022)
This chart shows how Briacell Therapeutics Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2017 to 2022. As of January 2026, the index stands at 1.9%, representing strategic assets of $582.46K against net assets of $30.21 Million USD. Explore Briacell Therapeutics Corp cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Briacell Therapeutics Corp (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Briacell Therapeutics Corp from 2017 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Briacell Therapeutics Corp market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $2.00 | $- | $2.00 | $13.25 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $- | $2.00 | $34.58 Million | ▼ 0.0 pp |
| 2018 | 0.0% | $2.00 | $- | $2.00 | $945.02K | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $- | $2.00 | $750.23K | — |